XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities (Tables)
3 Months Ended
Mar. 31, 2022
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities  
Schedule of marketable investment securities, restricted cash and cash equivalents, and other investment securities

As of

March 31,

December 31,

2022

    

2021

 

(In thousands)

Marketable investment securities:

Current marketable investment securities:

Strategic - available-for-sale

$

144

$

152

Strategic - trading/equity

1,455

1,895

Other

537,176

2,973,471

Total current marketable investment securities

538,775

2,975,518

Restricted marketable investment securities (1)

2,500

28,696

Total marketable investment securities

541,275

3,004,214

Restricted cash and cash equivalents (1)

102,551

5,306,072

Other investment securities:

Other investment securities

141,045

150,941

Total other investment securities

141,045

150,941

Total marketable investment securities, restricted cash and cash equivalents, and other investment securities

$

784,871

$

8,461,227

(1)Restricted marketable investment securities and restricted cash and cash equivalents are included in “Restricted cash, cash equivalents and marketable investment securities” on our Condensed Consolidated Balance Sheets.
Schedule of fair value measurements

As of

March 31, 2022

December 31, 2021

    

Total  

    

Level 1

    

Level 2

    

Level 3

    

Total  

    

Level 1

    

Level 2

    

Level 3

 

(In thousands)

Cash equivalents (including restricted)

$

2,672,633

$

230,850

$

2,441,783

$

$

7,592,696

$

83,302

$

7,509,394

$

 

Debt securities (including restricted):

Commercial paper

$

358,994

$

$

358,994

$

$

2,533,875

$

$

2,533,875

$

Corporate securities

180,246

180,246

462,999

462,999

Other

580

436

144

5,445

5,293

152

Equity securities

1,455

1,455

1,895

1,895

Total

$

541,275

$

1,455

$

539,676

$

144

$

3,004,214

$

1,895

$

3,002,167

$

152

Schedule of gains and losses on sales and changes in carrying amounts of investments

For the Three Months Ended 

March 31,

Other, net:

    

2022

    

2021

    

 

(In thousands)

Marketable investment securities - realized and unrealized gains (losses)

$

(448)

$

317

Derivative instruments - net realized and/or unrealized gains (losses) (1)

43,000

(4,000)

Costs related to early redemption of debt

(6)

(2,600)

Equity in earnings (losses) of affiliates

400

817

Other

(398)

205

Total

$

42,548

$

(5,261)